Portable Sequencer Provides Real-Time Outbreak Surveillance

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Real-time genomic surveillance is possible in resource-limited settings to monitor infectious disease outbreaks, according to a … [Read more...]

2015 Had Promising Signs Amid Tough Fundraising Climate for Dx Cos

Last year was a "banner" year for investment activity in the health care industry. Overall, in 2015, venture capital (VC) investment in health care hit a 15-year high, reaching roughly $59 … [Read more...]


Few Non-Academic Hospitals Planning for Precision Medicine

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Except for academic medical centers, few hospital executives see personalized medicine playing a significant role at their … [Read more...]

T2 Biosystems Shifts Paradigm for Rapid Pathogen Identification Directly From Sample

T2 Biosystems (Lexington, Mass.) is set to revolutionize diagnosis of sepsis infections. Within hours of sample receipt, the company’s T2 Magnetic Resonance (T2MR) platform can identify the … [Read more...]

Payment Reform Efforts to Support Cancer Care Coordination, Treatment Planning

The American Society of Clinical Oncology (ASCO) is proposing to profoundly reform payment for cancer care. ASCO's Patient-Centered Oncology Payment: Payment Reform to Support Higher Quality, More … [Read more...]

Faster Genome Analysis Enabling Clinical Application, Population-Scale Translational Research

Genome analysis pipelines are getting faster. These advances in computational pipelines are going to alleviate the notorious analysis bottleneck that challenges clinical adoption of genome sequencing. … [Read more...]

G2 Index Up Nearly 50% for 2013; Half of Diagnostics Companies Surpass Broader Market

The G2 Diagnostic Stock Index gained about 14 percent for the second half of the year (July 26 to Dec. 27) and was up nearly 50 percent for the full year 2013 (Jan. 2 to Dec. 27). Thirteen stocks … [Read more...]

G2 Index Up 9% in 2014, Surpassing Broader Market

The G2 Diagnostic Stock Index gained over 9 percent for the first half of the year (Jan. 2 to July 31). Ten stocks increased for the period, while five stocks lost ground. The G2 Diagnostic Stock … [Read more...]